GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) » Definitions » Cyclically Adjusted PS Ratio

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Cyclically Adjusted PS Ratio : 2.93 (As of May. 15, 2024)


View and export this data going back to 1997. Start your Free Trial

What is China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted PS Ratio?

As of today (2024-05-15), China Resources Double-Crane Pharmaceutical Co's current share price is ¥23.38. China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥7.99. China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is 2.93.

The historical rank and industry rank for China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SHSE:600062' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.41   Med: 1.99   Max: 4.28
Current: 2.95

During the past years, China Resources Double-Crane Pharmaceutical Co's highest Cyclically Adjusted PS Ratio was 4.28. The lowest was 1.41. And the median was 1.99.

SHSE:600062's Cyclically Adjusted PS Ratio is ranked worse than
61.88% of 745 companies
in the Drug Manufacturers industry
Industry Median: 2.17 vs SHSE:600062: 2.95

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

China Resources Double-Crane Pharmaceutical Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥2.760. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥7.99 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

China Resources Double-Crane Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.67 1.53 1.70 2.27 2.37

China Resources Double-Crane Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.19 2.23 2.24 2.37 2.59

Competitive Comparison of China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=23.38/7.99
=2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, China Resources Double-Crane Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.76/114.6694*114.6694
=2.760

Current CPI (Mar. 2024) = 114.6694.

China Resources Double-Crane Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 1.357 98.200 1.585
201409 1.281 98.900 1.485
201412 1.857 99.000 2.151
201503 1.250 99.900 1.435
201506 1.214 99.500 1.399
201509 1.175 100.500 1.341
201512 1.286 100.600 1.466
201603 1.380 102.200 1.548
201606 0.963 101.400 1.089
201609 1.248 102.400 1.398
201612 1.291 102.600 1.443
201703 1.465 103.200 1.628
201706 1.060 103.100 1.179
201709 1.610 104.100 1.773
201712 1.597 104.500 1.752
201803 2.049 105.300 2.231
201806 1.869 104.900 2.043
201809 2.129 106.600 2.290
201812 1.836 106.500 1.977
201903 2.524 107.700 2.687
201906 2.140 107.700 2.278
201909 2.436 109.800 2.544
201912 1.893 111.200 1.952
202003 2.092 112.300 2.136
202006 1.884 110.400 1.957
202009 2.135 111.700 2.192
202012 2.042 111.500 2.100
202103 2.308 112.662 2.349
202106 2.131 111.769 2.186
202109 2.152 112.215 2.199
202112 2.143 113.108 2.173
202203 2.414 114.335 2.421
202206 2.358 114.558 2.360
202209 2.148 115.339 2.136
202212 2.322 115.116 2.313
202303 2.701 115.116 2.691
202306 2.377 114.558 2.379
202309 2.262 115.339 2.249
202312 2.618 114.669 2.618
202403 2.760 114.669 2.760

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


China Resources Double-Crane Pharmaceutical Co  (SHSE:600062) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


China Resources Double-Crane Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of China Resources Double-Crane Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Business Description

Traded in Other Exchanges
N/A
Address
No. 1, East Second Road, Lijing, Wangjing, Chaoyang District, Beijing, CHN, 100102
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.

China Resources Double-Crane Pharmaceutical Co (SHSE:600062) Headlines

No Headlines